Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bridgebio Pharma Inc 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 USA

www.bridgebio.com Employees: 730 P: 650-391-9740

Sector:

Medical

Description:

BridgeBio Pharma Inc. is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio Pharma Inc. is based in PALO ALTO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 15,012,030
Enterprise Value, $K 16,052,320
Shares Outstanding, K 192,709
Float, K 157,636
% Float 81.80%
Short Interest, K 18,793
Short Float 9.75%
Days to Cover 10.18
Short Volume Ratio 0.82
% of Insider Shareholders 18.20%
% of Institutional Shareholders 99.85%
Annual Net Income, $ -535,760 K
Last Quarter Sales, $ 120,700 K
Last Quarter Net Income, $ -182,740 K
EBIT, $ -609,880 K
EBITDA, $ -603,800 K
3-Year Return 824.08%
5-Year Return 236.36%
5-Year Revenue Growth 447.09%
5-Year Earnings Growth -31.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 10/29/25
Next Earnings Date 02/19/26
Earnings Per Share ttm -4.09
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -10.47%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 3-1 on 12/27/21

BBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -80.47%
Profit Margin % -241.44%
Debt/Equity -0.96
Price/Sales 41.95
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -9.98
Interest Coverage -4.46
60-Month Beta 1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar